Medicare Enrolled

Dr. Amardeep Mann, M.D.

Cardiovascular Disease · Pasco, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
520 N 4TH AVE, Pasco, WA 99301
5094168882
In practice since 2006 (20 years)
NPI: 1396715181 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mann from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mann? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mann

Dr. Amardeep Mann is a cardiovascular disease specialist in Pasco, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mann performed 641 Medicare services across 506 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mann received a total of $18,697 from 24 pharmaceutical and/or device companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mann is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 641 Medicare services $18,697 industry payments

Medicare Practice Summary

Medicare Utilization ↗
641
Medicare services
Bottom 20% in WA for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
506
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
EKG interpretation and report
A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report.
265 $6 $69
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
120 $77 $195
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
106 $106 $266
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
75 $52 $132
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
61 $62 $165
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
14 $20 $54
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,697
Total received (2018-2024)
Avg $2,671/year across 7 years
Top 10% in WA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
195
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13,297 (71.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,401 (28.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$742
2023
$2,776
2022
$5,763
2021
$3,432
2020
$4,587
2019
$1,221
2018
$177

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$93
Takeda Pharmaceuticals U.S.A., Inc.
$93
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Abbott Laboratories
$71
Amgen Inc.
$58
Medtronic, Inc.
$56
Novartis Pharmaceuticals Corporation
$48
AstraZeneca Pharmaceuticals LP
$39
United Therapeutics Corporation
$31
Otsuka America Pharmaceutical, Inc.
$28
iRhythm Technologies, Inc.
$27
Braintree Laboratories, Inc.
$23
Alnylam Pharmaceuticals Inc.
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
E.R. Squibb & Sons, L.L.C.
$19
Merck Sharp & Dohme LLC
$17
Phathom Pharmaceuticals, Inc.
$14
Top 3 companies account for 35.8% of 2024 payments
All-time payments by company (2018-2024) ›
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$13,624
Abbott Laboratories
$3,072
Medtronic, Inc.
$841
PFIZER INC.
$234
Boehringer Ingelheim Pharmaceuticals, Inc.
$131
Amgen Inc.
$123
Takeda Pharmaceuticals U.S.A., Inc.
$93
Kowa Pharmaceuticals America, Inc.
$70
AstraZeneca Pharmaceuticals LP
$55
W. L. Gore & Associates, Inc.
$53
Merck Sharp & Dohme LLC
$49
Novartis Pharmaceuticals Corporation
$48
Braintree Laboratories, Inc.
$40
Janssen Pharmaceuticals, Inc
$36
E.R. Squibb & Sons, L.L.C.
$33
United Therapeutics Corporation
$31
Otsuka America Pharmaceutical, Inc.
$28
iRhythm Technologies, Inc.
$27
Alnylam Pharmaceuticals Inc.
$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
QOL Medical, LLC
$20
Innovation Technologies Inc
$17
Phathom Pharmaceuticals, Inc.
$14
Novo Nordisk Inc
$13
Top 3 companies account for 93.8% of all-time payments
Associated products mentioned in payments ›
ASSURITY · AZURE XT DR MRI SURESCAN · Allure CRT Pacemaker · Assurity Pacemaker · CAPVAXIVE · CONFIRM RX · Confirm Rx · ELIQUIS · ENTYVIO · Ellipse ICD · FARXIGA · Fortify Assura · GALLANT · GORE VIABAHN Endoprosthesis with Heparin · IRRISEPT · JARDIANCE · JOT DX · LEQVIO · LINQ II · LOKELMA · LifeVest · Livalo · ORENITRAM · OXLUMO · QUADRA ALLURE MP · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · REXULTI · Repatha · SUFLAVE · SUTAB · Sucraid · VENASEAL · VERQUVO · VIABAHN Endoprosthesis with PROPATEN Bioactive Surface · VOQUEZNA · VYNDAQEL · Wegovy · XARELTO · XIFAXAN · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (71%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for cardiovascular disease in WA.

Looking for a cardiovascular disease specialist in Pasco?
Compare cardiologists in the Pasco area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
14
Per 100K population
14.3
County median income
$82,755
Nearest hospital
LOURDES MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mann is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 10% of WA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mann experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Mann performed 265 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mann receive payments from pharmaceutical companies?
Yes. Dr. Mann received a total of $18,697 from 24 companies across 195 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mann's costs compare to other cardiologists in Pasco?
Dr. Mann's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mann) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →